Home › Funds › Spruce Street Capital LP › DNTH

Spruce Street Capital LP position in DNTH

DIANTHUS THERAPEUTICS INC · Health Care

Spruce Street Capital LP reported holding 354,816 shares of DNTH (DIANTHUS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$31.2M, representing 4.97% of its reported portfolio and ranking #7 among its reported holdings. Spruce Street Capital LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)354.82K sh
Reported value held$31.24M
Portfolio Weight4.97%
First reportedQ4 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Spruce Street Capital LP's DNTH position evolved

Spruce Street Capital LP first disclosed a stake in DNTH in Q4 2025 at 297,437 shares (US$12.3M). The position peaked in Q2 2026 at 354,816 shares, worth US$34.6M. Across 4 filings, Spruce Street Capital LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 354,816 shares valued at US$31.2M. Notable position changes include a 25% increase in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 297.44K $12.26M New
Q1 2026 373.27K $31.33M Add
Q2 2026 354.82K $34.59M Reduce
Q3 2026 354.82K $31.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNTH and 13F data

DNTH (DIANTHUS THERAPEUTICS INC) is a Health Care company. 60 other funds we track also report a position in DNTH — the largest reported positions include Fairmount Funds Management LLC (US$247.3M), Avidity Partners Management LP (US$205.1M), Octagon Capital Advisors LP (US$179.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNTH

All DNTH fund holders →

FAQ

How long has Spruce Street Capital LP held DNTH?

Spruce Street Capital LP has disclosed DNTH holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Spruce Street Capital LP's current position in DNTH?

As of Q3 2026, Spruce Street Capital LP holds 354.82K shares of DNTH (DIANTHUS THERAPEUTICS INC), valued at $31.24M, representing 4.97% of its reported portfolio and ranking #7.

Has Spruce Street Capital LP been buying or selling DNTH?

In the latest 13F filing (Q3 2026), Spruce Street Capital LP held unchanged its position in DNTH. The position peaked in Q2 2026 at 354.82K shares.

Which other funds hold DNTH?

Other major institutional holders of DNTH include Fairmount Funds Management LLC, Avidity Partners Management LP, Octagon Capital Advisors LP, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.